InvestorsHub Logo
Replies to #26757 on Biotech Values

io_io

04/05/06 8:39 AM

#26760 RE: spartex #26757

re: Discovery Labs Receives Second Approvable Letter From FDA for Surfaxin for RDS


All I can say is "Ouch".

Plus that DSCO seems to have the absolute very worst management in all of biotech - their drug can perform, but they can not.